Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | EDNRA | P25101 | 2/20 | 0.33 |
| ▸ | EDNRB | P24530 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10098624 | 0.99 | L3MBTL1 (0.39) | L3MBTL1KDM4EATMKMT2AEDNRA | |
| SCHEMBL29373262 | 0.97 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMKMT2AEDNRA | |
| SCHEMBL282306 | 0.97 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMKMT2AEDNRA | |
| SCHEMBL14521285 | 0.96 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2AEDNRA | |
| SCHEMBL14362587 | 0.96 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2AEDNRA | |
| SCHEMBL14564972 | 0.96 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2AEDNRA | |
| SCHEMBL10098590 | 0.96 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2AEDNRA | |
| SCHEMBL10098591 | 0.96 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2AEDNRA | |
| SCHEMBL14564954 | 0.96 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMKMT2AEDNRA | |
| SCHEMBL261368 | 0.94 | KDM4E (0.49) | L3MBTL1KDM4EATMKMT2AEDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130005067-A1 | Anthracene Derivative, Material For Light Emitting Element, Light Emitting Element, Light Emitting Device, And Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-01-03 | — | — | US | disclosed |
| US-20130005067-A1 | Anthracene Derivative, Material For Light Emitting Element, Light Emitting Element, Light Emitting Device, And Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-01-03 | — | — | US | disclosed |
| US-8298687-B2 | Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-30 | — | — | US | disclosed |
| US-8298687-B2 | Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-30 | — | — | US | disclosed |
| EP-2479814-A1 | Light emitting device comprising a carbazole-anthracene derivative | Semiconductor Energy Laboratory Co, Ltd. (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120007066-A1 | ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-01-12 | — | — | US | disclosed |
| US-20120007066-A1 | ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-01-12 | — | — | US | disclosed |
| US-8039122-B2 | Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-10-18 | — | — | US | disclosed |
| US-8039122-B2 | Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20090015140-A1 | Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-01-15 | — | — | US | disclosed |
| US-20090015140-A1 | Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-01-15 | — | — | US | disclosed |
| US-20080286445-A1 | COMPOSITION, AND METHOD OF FABRICATING LIGHT-EMITTING ELEMENT | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-11-20 | — | — | US | disclosed |
| US-20080286445-A1 | COMPOSITION, AND METHOD OF FABRICATING LIGHT-EMITTING ELEMENT | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090015140-A1 | Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device | CRY1, CRY2, CYBA | L3MBTL1 3184/4885KDM4E 2566/4885ATM 729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.